Target intelligence / Profile preview

Long intergenic non-protein coding RNA 310 (LINC00310)

Target
LINC00310
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 310 (LINC00310) is a long non-coding RNA molecule encoded by the human LINC00310 gene, also known as C21orf82 or NCRNA00310, located on chromosome 21. Functionally, LINC00310 acts as a regulatory RNA, promoting breast cancer cell proliferation and tumor growth, primarily by regulating classical oncogenes such as c-Myc and cell cycle regulators like CDK4. Knockout of LINC00310 suppresses tumor growth both in vitro and in vivo, indicating a proto-oncogenic role. Elevated LINC00310 expression is associated with breast cancer progression and reduced patient survival; its increased levels in serum can serve as a diagnostic and prognostic biomarker for breast cancer, with high specificity and sensitivity for distinguishing disease state. Although not considered a classical drug target, it is of significant interest as a clinical marker and molecular modulator in oncology research. No antagonists or modulators targeting this RNA are in clinical use.

Other names
C21orf82NCRNA00310chromosome 21 open reading frame 82NONHSAG032733.2HSALNG0132830GC21P035553GC21P034180GC21P034157GC21P034294
02

Biological functions

Regulation of cell proliferationTumor growth and progressionRegulation of cell cycle
03

Disease associations

Cancer
04

Biomarkers

Serum LINC00310 expression

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 310 (LINC00310).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 310 (LINC00310).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call